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Abstract The cardioprotection afforded by remote
ischaemic conditioning (RIC) is mediated via a complex
mechanism involving sensory afferent nerves, the vagus
nerve, and release of a humoral blood-borne factor. How-
ever, it is unknown whether release of the protective factor
depends on vagal activation or occurs independently. This
study aimed to evaluate the co-dependence of the neural
and humoral pathways of RIC, focussing on the vagus
nerve and intrinsic cardiac ganglia. In the first study,
anesthetised rats received bilateral cervical vagotomy or
sham-surgery immediately prior to RIC (4 9 5 min limb
ischemia–reperfusion) or sham-RIC. Venous blood plasma
was dialysed across a 12–14 kDa membrane and dialysate
perfused through a naı¨ve-isolated rat heart prior to 35-min
left anterior descending ischemia and 60-min reperfusion.
In the second study, anesthetised rats received RIC (4 9
5-min limb ischemia–reperfusion) or control (sham-RIC).
Dialysate was prepared and perfused through a naı¨ve-iso-
lated rat heart in the presence of the ganglionic blocker
hexamethonium or muscarinic antagonist atropine, prior to
ischemia–reperfusion as above. Dialysate collected from
RIC-treated rats reduced infarct size in naı¨ve rat hearts
from 40.7 ± 6.3 to 23.7 ± 3.1 %, p\ 0.05. Following
bilateral cervical vagotomy, the protection of RIC dialysate
was abrogated (42.2 ± 3.2 %, p\ 0.05 vs RIC dialysate).
In the second study, the administration of 50-lM
hexamethonium (45.8 ± 2.5 %) or 100-nM atropine
(36.5 ± 3.4 %) abrogated the dialysate-mediated protec-
tion. Release of a protective factor following RIC is
dependent on prior activation of the vagus nerve. In addi-
tion, this factor appears to induce cardioprotection via
recruitment of intrinsic cardiac ganglia.
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Introduction
Remote ischemic conditioning describes the cardioprotec-
tive intervention, whereby brief periods of ischemia to an
organ or tissue remote from the heart can protect the
myocardium from a subsequent injurious ischemic insult
[57]. This important discovery, further to that of classical
ischemic conditioning [55], gave immediate potential for
clinical translation. Indeed, since its inception in 1993,
there have been many attempts to prove its efficacy in
limiting injury associated with coronary artery bypass
(CABG) surgery and acute myocardial infarction in
patients, with varying levels of success [11, 14, 17, 30,
31, 53, 67, 71, 78, 80]. Perhaps a reason for this difficulty
in translation is a significant gap in our understanding of
the mechanism, in particular, how the protective message is
communicated from the conditioned limb to the myo-
cardium [33, 56]. This is the unique mechanistic trait of
RIC, thus understanding how it occurs is of great impor-
tance, and we believe would aid more effective clinical
translation.
The communication of RIC is classically thought to
occur via one of two pathways. First, a humoral pathway
whereby a factor is released in response to the conditioning
stimulus which moves to the heart via the circulatory
system and protects [20, 21, 46, 59, 66]. Second, a neural
pathway whereby the conditioning stimulus induces sen-
sory nerve firing which, via autonomic centres in the
brainstem, leads to increased efferent autonomic tone to the
heart, initiating cardioprotection [22, 26, 28, 47, 51]. These
two pathways were originally thought of as mechanistically
distinct; however, recent data have suggested that the two
are interdependent. Indeed, release of the humoral mediator
in response RIC is dependent on sensory innervation to the
conditioned limb [37, 52, 60, 70]. The downstream target
of sensory nerve activation leading to release of the
humoral factor, however, is not clear. One possibility is the
vagus nerve, which has been previously implicated in the
RIC mechanism [22, 51]. Indeed, a recent study suggested
vagal innervation to the gut was essential for the commu-
nication of RIC, perhaps, via release of a blood-borne
factor [50]. However, although it suggests release of a
factor is dependent on vagus nerve activation, these data
presented does not absolutely prove this link as release of a
humoral factor is not measured. This study investigates the
hypothesis that the humoral mediator is released down-
stream of vagus nerve activation.
There exist within the heart intrinsic neural loops that
are able to process sensory information from the myocar-
dial milieu and modulate efferent autonomic output from
intrinsic cardiac ganglia, without any necessary input from
the central nervous system [3, 5–7]. These neural loops are
at risk of destruction following myocardial infarction, and,
indeed, remodel, such that the intrinsic cardiac nervous
system (ICNS) no longer can function as normal
[1, 29, 36, 58]. Vagus nerve stimulation has recently been
demonstrated to ameliorate post-infarction remodelling of
the ICNS [8]. Thus, given the putative importance of the
vagus nerve in RIC, this study investigated the hypothesis
that intrinsic cardiac ganglia are recruited by the humoral
mediator of RIC as part of the transduction of protection
within the myocardium.
Materials and methods
Materials
Hexamethonium (Sigma-Aldrich, Missouri, USA) was
employed as a neuronal nicotinic acetylcholine receptor
(nAChR) antagonist. Given it has affinity to the muscarinic
M2 receptor above 100 lM [24], a dose of 50 lMwas used
for this study to aid specificity at nAChRs within cardiac
ganglia. Atropine, a muscarinic acetylcholine receptor
(mAChR) antagonist, was used at a dose of 100 nM.
Although often used at micromolar doses in the literature,
atropine has a high affinity for mAChRs (Kd = 0.36 nM
[72]). Thus, 100 nM was chosen, which has recently been
demonstrated to effectively antagonise muscarinic agonism
in isolated hearts [38].
Animals and ethical statement
All animals received humane care in accordance with the
United Kingdom (Scientific Procedures) Act of 1986. Male
Sprague–Dawley (SD) rats were bred at a central animal
unit in University College London and were used at a
weight of 250–300 g throughout the study.
In vivo procedure: donor rat
Male SD rats were anesthetised via an upper-left quadrant
intraperitoneal injection of 20 % w/v sodium pentobarbi-
tone (Animalcare, York, UK) at a dose of 0.05 ml/
100 g ? 0.05 ml. Once anesthesia was reached, confirmed
via loss of pedal reflex, the animal was secured in a supine
position on a heat mat. The rat was intubated via optic light
trans-illumination of the trachea, using a modified 16G,
1.7 9 51 mm Abbocath-T intravenous cannula (B. Braun,
PA, USA). This cannula was connected to either a Phys-
ioSuite (Kent Scientific, CT, USA) or Small Animal
Ventilator (Harvard Apparatus, Kent, UK), and ventilated
with air supplemented with 0.5 l/min oxygen. Finally, core
body temperature was maintained at 37.0 ± 0.5 C via a
rectal probe feeding back to a heat pad.
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Model characterisation
Animals had a small cuff placed around their left hindlimb
and were randomised to receive either (1) RIC protocol,
consisting of 4 9 5-min cuff inflation to 200 mmHg with
intermittent 5-min deflations, or, (2) sham-RIC protocol,
consisting of a corresponding time period with no cuff
inflation (see Fig. 1i). Following the procedure, a clamshell
thoracotomy was performed and the heart was excised and
perfused on a Langendorff apparatus, using the same
method as described below. Following a 20-min period of
stabilisation, hearts were subjected to a 35-min LAD
ischemia and subsequent 60-min reperfusion [25]
(Fig. 1ii). In a separate group of rats, blood was sampled
via cardiac puncture following the protocol and prepared
for dialysis as described below.
Dialysate preparation
At the end of the protocol, *9 ml of venous blood was
harvested via right ventricular puncture, following clam-
shell thoracotomy, using a 1.5-in 19G Terumo needle
Fig. 1 Design of experimental protocols: i displays in vivo proce-
dures. Anaesthetised rats were subjected to either RIC (4 9 5 min
hindlimb ischaemia/reperfusion) or sham protocols. Bilateral cervical
vagotomy or sham-surgery immediately prior to either RIC (4 9 5-
min limb ischaemia–reperfusion) or sham-RIC. ii At the end of this
protocol, the heart was excised and perfused on a Langendorff rig
before being subjected to a 35-min region ischaemia and 60-min
reperfusion. iii Following the in vivo procedure, 9-ml blood was
sampled and the plasma dialysed across a 12–14-kDa membrane. The
dialysate was perfused through a naı¨ve-isolated rat heart for 10 min
prior to a regional ischaemia–reperfusion protocol, as described
above. iv Isolated hearts were treated with either hexamethonium
(50 lM) or atropine (100 nM) for 5 min prior to and the duration of
dialysate perfusion/washout. Following each Langendorff experi-
ment, infarct size (IS) was determined using TTC staining
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(Egham, UK). Samples were immediately centrifuged at
1600g for 20 min at 21 C to obtain plasma, followed by
10,000g for 30 min at 21 C to obtain 4 ml of platelet-free
plasma. This was dialysed across a 12–14-kDa membrane
(Spectra/Por, Spectrum Laboratories, Inc., Rancho Dom-
inguez, CA, USA) into 200 ml of modified Krebs-Hense-
leit buffer (KHB) (118-mM NaCl, 4.7-mM KCl, 1.22-mM
MgSO47H2O, 1.21-mM KH2PO4, and 1.84-mM CaCl2-
2H2O) for 24 h at 4 C. Prior to perfusion through the
naı¨ve heart, the dialysate was supplemented with 25-mM
NaHCO3 and 11-mM D-glucose, gassed with 95 % O2 and
5 % CO2 and warmed to 37.5 C.
Naı¨ve recipient hearts
Rats were anesthetised with an upper-left quadrant
intraperitoneal injection of sodium pentobarbitone (60 mg/
kg) (Animalcare, York, UK). Hearts were quickly excised
via a clamshell thoracotomy and the aorta cannulated on a
Langendorff apparatus and perfused with KHB (118-mM
NaCl, 25-mM NaHCO3, 11-mM D-glucose, 4.7-mM KCl,
1.22-mM MgSO47H2O, 1.21-mM KH2PO4, and 1.84-mM
CaCl22H2O (for detailed methods, see [9]). A fluid-filled
latex balloon was inserted into the left ventricle to allow
for measurement of functional parameters, including heart
rate (HR) and left ventricular developed pressure
(LVEDP). Coronary flow rate (CFR) was recorded
throughout the protocol, and the temperature of the heart
was maintained at 37.0 ± 0.5 C. Finally, a 3–0 Mersilk
suture (Ethicon, Edinburgh, UK) was inserted through the
heart to surround the left anterior descending (LAD)
coronary artery. Following a 20-min stabilisation, dialysate
was perfused through the heart for 10 min with a subse-
quent 10-min washout before index ischemia. All hearts
received a 35-min LAD ischemia, induced via reversible
tightening of the suture, and 60-min reperfusion (Fig. 1iii).
Although there is evidence that reperfusion can influence
infarct size in mouse Langendorff [62], the use of 60-min
reperfusion duration, as opposed to 120 min, in the rat
Langendorff model does not influence the efficacy of
triphenyl-tetrazolium (TTC) staining [25].
Study 1: bilateral cervical vagotomy and RIC in rats
Anesthetised SD rats were randomly assigned to one of the
four groups: (1) Sham vagotomy ? Control, the left and right
vagus nerves were isolated at the mid-cervical level, but not
severed, and the rat received a sham-RIC protocol; (2) Sham
vagotomy ? RIC, the same as group 1; however, the rat was
subjected to RIC; (3) Vagotomy ? Control, rats were sub-
jected to bilateral cervical vagotomy and received a sham-
RIC protocol; and (4) Vagotomy ? RIC, rats were subjected
to bilateral cervical vagotomy and received RIC (Fig. 1i). At
the end of the protocol, blood was sampled via right ven-
tricular puncture and dialysate prepared as described above.
The dialysate was perfused through a naı¨ve-isolated rat heart
prior to IRI, also described above (Fig. 1iii).
Study 2: intrinsic cardiac nerves and RIC in rats
Isolated hearts were randomly assigned to one of the fol-
lowing six groups: (1) Control dialysate, hearts received
dialysate prepared from an in vivo rat following sham-RIC;
(2) RIC dialysate, hearts received dialysate prepared from
an in vivo rat following in vivo RIC; (3) Control
dialysate ? Hexamethonium (50 lM); (4) RIC dialysate ?
Hexamethonium; (5) Control dialysate ? Atropine (100 nM);
and (6) RIC dialysate ? Atropine (100 nM) (Fig. 1iv). In
groups 3–6, drug perfusion was initiated 5 min prior to and
for the duration of dialysate treatment. The choices of drug
concentration were chosen carefully, as described above.
All hearts were perfused with the dialysate for 10 min, with
a subsequent 10-min washout period, prior to IRI, as
described above.
Infarct size assessment
At the end of the reperfusion period, the LAD suture was
re-tightened and 1 ml of 0.25 % Evans blue dye was per-
fused through the heart to delineate the area-at-risk of
infarction. The hearts were then frozen at -20 C before
being sectioned into five-transverse slices and stained for
viable tissue by immersion in 1 % triphenyl-tetrazolium
chloride at 37 C for 15 min. Following fixation in 10 %
formalin for 24 h, the sections were digitally scanned to a
computer for analysis. Analysis of infarct size (IS) as a
proportion of area-at-risk (AAR) was calculated via
planimetry using the ImageJ software (version 1.45,
National Institutes of Health, USA). Infarct size was cal-
culated a percentage of the area-at-risk (IS/AAR).
Bicinchoninic acid (BCA) assay to measure dialysate
and plasma protein concentration
Plasma or dialysate samples were assayed for protein
concentration using the BCA assay method, as described
previously [68]. Briefly, 5 ll of each sample is added to a
96-well plate, followed by 195 ll of a 1:50 mix of copper
II sulphate and bicinchoninic acid. This is allowed to
incubate for 30 min at 37 C before being subjected to
colorimetric analysis at 470 nm.
Statistics
Data groups were first analysed for normality using the
Kolmogorov–Smirnov test. Statistical differences between
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two groups were analysed using a student’s t test and more
than two groups using a one-way analysis of variance
(ANOVA) with Tukey’s multiple comparison post-test.
Haemodynamic data in Figs. 4 and 5 were analysed using a
two-way repeated measures ANOVA with Bonferroni’s
post-test. All data are presented as mean ± standard error
of the mean (SEM). Data groups were classed as signifi-
cantly different with a p value less than 0.05. Notation of
significance was as follows: * = p\ 0.05, ** = p\ 0.01,
and *** = p\ 0.001. Analysis was exclusively performed
using GraphPad Prism version 5 for Windows (CA, USA).
Results
In vivo RIC induces significant cardioprotection
The RIC protocol of 4 9 5-min hindlimb ischemia–reper-
fusion, induced via a small blood-pressure cuff, was
effective at inducing cardioprotection in vivo, as demon-
strated by a significantly reduced infarct size in hearts
subjected to RIC relative to sham procedure (sham IS/
AAR = 61.7 ± 1.9 % vs RIC IS/AAR = 46.9 ± 4.6 %,
p\ 0.05) (Fig. 2d).
Model characterisation: RIC dialysate is
cardioprotective to a naı¨ve-isolated rat heart
The dialysate transfer model has previously only been
described in the rabbit [37, 61, 70] and mouse [34]. Whilst
plasma transfer from pig to rat heart has been proven [66],
it was important to characterise the dialysate model in the
rat. We initially took platelet-rich plasma from sham- or
RIC-treated rats, dialysed across a 12–14-kDa membrane
into a 50-fold volume of buffer, and perfused this through
naı¨ve-isolated rat hearts prior to ischemia–reperfusion
injury (IRI). The RIC dialysate provided a significant
protection to the naı¨ve-isolated heart (sham dialysate
IS/AAR = 26.4 ± 1.0 % vs RIC dialysate IS/AAR =
16.7 ± 1.5 %, p\ 0.01, n = 6–8 per group) (Fig. 2e).
However, the infarct size in isolated hearts that were per-
fused with the sham dialysate was unexpectedly small in
comparison to typical control infarct sizes. In contrast,
when platelets were removed from the plasma by cen-
trifugation, infarct sizes were more typical, and RIC
remained fully effective (sham dialysate IS/AAR =
41.5 ± 1.7 % vs RIC dialysate IS/AAR = 25.2 ± 2.6 %,
p\ 0.001, n = 6–8 per group) (Fig. 2f). We, therefore,
used platelet-free plasma in further studies.
The concentration of protein within the plasma and
dialysate did not differ between sham and RIC groups
(sham = 0.09 ± 0.02 lg/ll vs RIC = 0.11 ± 0.002 lg/
ll, n = 6/group, p[ 0.05). There were no differences
observed in the plasma protein concentration between RIC
and sham groups before or after dialysis. With the 50-fold
dilution and 12–14-kDa dialysis cutoff, a 400-fold decrease
in protein concentration was observed between plasma and
dialysate.
Study 1: bilateral cervical vagotomy abolishes
release of the humoral mediator following RIC
Sham surgical vagotomy did not influence the efficacy of
RIC dialysate to protect a naı¨ve, isolated rat heart (control
dialysate from sham-surgery rat: IS/AAR = 40.7 ± 6.3 %
vs RIC dialysate from sham-surgery rat IS/AAR =
23.7 ± 3.1, p\ 0.05) (Fig. 3). When the vagus nerve was
sectioned bilaterally at the cervical level, RIC dialysate no
longer protected the naı¨ve-isolated heart (control dialysate
from vagotomised rat: IS/AAR = 31.4 ± 2.4 % vs RIC
dialysate from vagotomised rat: IS/AAR = 42.2 ± 3.2 %,
p\ 0.05 vs sham-surgery RIC dialysate) (Fig. 3).
The hemodynamic data for the naı¨ve-isolated hearts that
received dialysate are shown in supplementary Fig. 5.
Measurements were taken at the beginning of stabilisation,
5 min into the index ischemia and at the end of 60-min
reperfusion. Those hearts treated with RIC dialysate did not
demonstrate improved functional recovery as measured by
coronary flow rate (CFR), left ventricular developed pres-
sure (LVEDP), and heart rate (HR). In addition, dialysate
prepared following bilateral cervical vagotomy did not
affect the functional recovery when perfused through a
naı¨ve-isolated heart.
Study 2: the humoral RIC mediator exerts
protection via intrinsic cardiac nerves
Figure 4 displays the infarct size chart and corresponding
functional data from naı¨ve-isolated rat hearts subjected to
dialysate in the presence or absence of either the ganglionic
blocker hexamethonium or the muscarinic antagonist atro-
pine. Those hearts treated with RIC dialysate in the absence
of either drug-induced powerful cardioprotection (sham
dialysate IS/AAR = 40.1 ± 1.2 vs RIC dialysate IS/AAR =
27.6 ± 2.3, p\ 0.05). In the presence of hexamethonium
(50 lM), RIC dialysate was no longer able to protect naı¨ve
hearts (sham dialysate ? Hex IS/AAR = 42.3 ± 4.3 % vs
RIC dialysate ? Hex IS/AAR = 45.8 ± 2.7 %, p[ 0.05 vs
sham dialysate). The muscarinic antagonist atropine
(100 nM) also abrogated RIC dialysate-mediated cardio-
protection (sham dialysate ? atropine IS/AAR = 40.7 ±
4.8 % vs RIC dialysate ? atropine IS/AAR = 36.5 ±
3.4 %, p[ 0.05 vs sham dialysate) (Fig. 4).
The hemodynamic data again indicated that RIC dialy-
sate did not significantly influence functional recovery of
naı¨ve hearts relative to control (Supp. Fig. 6). In addition,
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neither hexamethonium nor atropine affected functional
recovery of the isolated hearts.
Discussion
Our study elucidates two novel aspects to the mechanism
of RIC communication. First, release of the blood-borne
humoral mediator is dependent on prior activation of the
vagus nerve. Second, the humoral mediator exerts cardio-
protection in the myocardium in part via the recruitment of
intrinsic cardiac ganglia. Whilst the importance of the
vagus nerve in RIC has been previously reported
[22, 23, 50, 51], this study is the first to prove its
involvement in the release of the humoral mediator. We
have demonstrated that a plasma dialysate generated fol-
lowing in vivo RIC in rats is able to significantly protect a
naı¨ve-isolated rat heart from ischemia–reperfusion injury.
Fig. 2 Characterisation of the rat dialysate model: a–c BCA protein
assay was employed to measure protein concentration in the plasma
following either RIC (4 9 5-min hindlimb ischaemia/reperfusion) or
sham-surgery. No difference in plasma concentration was observed
between pre- and post-dialysis groups, and no difference was
observed following RIC relative to sham. Interestingly, a 400-fold
reduction in protein concentration was observed within the dialysate
when compared to plasma. d In vivo RIC or sham procedures
preceded excision of the heart and perfusion on a Langendorff
apparatus. These hearts were subjected to IRI, and those who had
received RIC displayed reduced infarct size relative to control.
e Dialysate was initially prepared using platelet-rich plasma. When
perfused through a naı¨ve-isolated heart, dialysate from both RIC and
sham-treated rats gave a protected phenotype, although RIC dialysate
still gave a significant additive protection. When platelets were
removed from the plasma prior to dialysis (f), sham dialysate no
longer gave a protective phenotype; however, RIC dialysate was able
to significantly protect naı¨ve hearts. Data were analysed via student’s
t test, n = 6–8 per group, and expressed as mean ± SEM
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Previous studies have prepared dialysate from an in vivo
rabbit model [52, 60, 70] or, indeed, humans [34, 37, 64].
These used a 20-fold dilution gradient into the dialysate,
which is 2.5-fold lower than the 50-fold dilution used in
this study. This demonstrates both the conserved nature of
the RIC mechanism across several mammalian species and
the remarkable potency of cardioprotection offered by the
factor(s). The interesting observation that platelet-rich
plasma generates a cardioprotective dialysate is most likely
a systematic effect. Platelets are thought to degranulate at
low temperatures [54], and when activated are known to
release several cardioprotective molecules that are smaller
than 12–14 kDa, for example, stromal-derived factor 1a
[13, 15, 16, 20, 49]. The plasma is dialysed at 4 C,
therefore, during this process, the platelets may degranulate
and release these cardioprotective factors. However, this
was not investigated in this study, and instead, platelet-free
plasma was used for dialysis in the two subsequent
experiments. Finally, recent evidence from our labora-
tory has suggested that the duration of reperfusion may
influence the magnitude of protection induced by pre-
conditioning [62], perhaps due to limitations of the TTC
method of infarct analysis. The evidence in rat Langendorff
studies, however, indicates that one can observe powerful
Fig. 3 Bilateral cervical vagotomy abrogates dialysate-mediated
protection of naı¨ve-isolated rat hearts: the chart displays left
ventricular infarct size as a proportion of the area-at-risk. Dialysate
was prepared following in vivo vagotomy or sham-surgery matched
with either RIC or sham protocols. This was perfused through a naı¨ve-
isolated heart prior to IRI. Sham vagotomy did not influence the
ability of RIC dialysate to induce cardioprotection in the naı¨ve heart.
Bilateral cervical vagotomy, however, abrogated RIC dialysate
protection in the naı¨ve heart, suggesting that release of the blood-
borne humoral mediator was inhibited. Data were analysed via one-
way ANOVA with Tukey’s post-hoc test, and presented as mean ± -
SEM, with 6–8 animals per group
Fig. 4 Hexamethonium and atropine abrogate dialysate-mediated
cardioprotection: isolated rat hearts were perfused with dialysate
prepared following in vivo RIC or sham procedures. RIC dialysate
significantly protected the naı¨ve heart from IRI relative to sham.
When the naı¨ve heart was pre-treated with either the ganglionic
antagonist hexamethonium (50 lM) or the muscarinic antagonist
atropine (100 nM) abrogated this protection. Data expressed as
mean ± SEM, n = 6–8 per group
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cardioprotection at both 60 min [79] and 120 min [32] of
reperfusion. Thus, the use of 60 min reperfusion can give
an accurate account of infarct size within the confines of
the TTC staining method.
Vagus nerve stimulation has been reported in the liter-
ature to offer significant cardioprotection from ischemia–
reperfusion injury [22, 51, 65, 73]. Indeed, an important
study by Mastitskaya et al. demonstrated that activation of
a particular group of pre-ganglionic parasympathetic neu-
rones, in the dorsal vagal motor nucleus (DVMN), was
sufficient to induce powerful cardioprotection in vivo [51].
In a subsequent and very elegant experiment, the DVMN
was genetically silenced using the allatostatin method
[51, 76]. This process abrogated RIC-mediated cardiopro-
tection, indicating that this group of pre-ganglionic
parasympathetic neurones is fundamental for the commu-
nication of the protective message from the conditioned
limb to the myocardium. Moreover, a recent study from the
same group indicates vagal innervation to the stomach, and
gut is responsible for RIC communication, suggesting the
release of a blood-borne mediator following vagal
recruitment [50]. The literature, however, is not fully in
agreement with these data [23]. Donato and colleagues
demonstrated that cervical but not sub-diaphragmatic
vagotomy abrogated RIC, suggesting direct cardiac vagal
innervation to be key for RIC communication. The absence
of a sham sub-diaphragmatic vagotomy group, however,
calls the result into question given the huge abdominal
trauma associated with the abdominal surgery. In addition,
release of a humoral cardioprotective mediator downstream
of vagus nerve activation has not been demonstrated in the
literature. The key result from our study, therefore, is that
release of the humoral RIC mediator is dependent on prior
activation of the vagus nerve. We further conclude that the
humoral factor is released from a region of the body
innervated by the vagus nerve below the cervical level.
Whether this factor is released following non-cardiac vagal
innervation, however, is not clear.
Release of the humoral mediator following RIC is
dependent on an intact sensory innervation to the condi-
tioned limb [37, 70]. In addition, two important studies
demonstrated that direct femoral nerve stimulation, topical
application of capsaicin or, indeed, transcutaneous elec-
trical nerve stimulation generated a plasma dialysate that
was able to protect a naı¨ve heart from ischemia–reperfu-
sion injury [52, 61]. These data suggest that the sensory
afferent nerve is the sole means of communication from the
conditioned limb, and that the factor is released down-
stream of nerve stimulation. Our study, perhaps, adds to the
model by suggesting that the vagus nerve is the link
between sensory nerve activation in the limb and release of
the humoral mediator (Fig. 5).
Fig. 5 Schematic of proposed
mechanism of RIC
communication (figure adapted
from [56]): serial inflations and
deflations of a cuff around the
upper limb will activate sensory
afferent nerves [70]. These, in
turn, will convey their message
to autonomic regions of the
brainstem, leading to increased
systemic efferent vagal tone.
The vagus nerve will innervate
an organ remote from the heart,
which induces release of a
dialysable cardioprotective
factor less than 12–14 kDa in
size. This factor will move to
the heart via the blood and
induce a protective phenotype
within the myocardium, in part
via the recruitment of intrinsic
cardiac ganglia
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Growing evidence suggests that cardiac neural control is
hierarchical. Indeed, sensory information from the heart
can be received by: (1) central nervous control from
medullary autonomic centres in the brain, which provide
information to the heart via autonomic efferent pre-gan-
glionic neurons; (2) intrathoracic extracardiac ganglia; (3)
intrinsic cardiac ganglia [2–6, 35, 41, 48]. Intrinsic cardiac
ganglia are able to process sensory information from the
myocardium and directly activate efferent post-ganglionic
nerve firing from intrinsic cardiac ganglia, thus neural
control of the heart can occur without any extracardiac
input [7, 41, 42]. The Langendorff perfused isolated heart
is traditionally thought of as a denervated preparation;
however, in light of recent studies in the literature descri-
bed above, as well as the results from this paper, it appears
that intrinsic neural loops remain intact in the isolated heart
and continue to play an important role in its function and
ability to withstand ischemia–reperfusion injury.
Transmission of a sensory message in a pre-ganglionic
synapse within intrinsic cardiac ganglia is governed via the
release of acetylcholine into the synaptic cleft, which will
bind to and activate nicotinic acetylcholine receptors
(nAChR), on the post-ganglionic nerve, causing a depo-
larisation and initiation of the nerve impulse [10, 19, 27].
Hexamethonium will antagonise the nAChR, thus pre-
venting transmission of information at the ganglia. The
observation, therefore, that hexamethonium abrogates dia-
lysate-mediated protection suggests that the humoral factor
recruits intrinsic cardiac ganglia as an essential process in
the induction of cardioprotection. Muscarinic acetylcholine
receptors (mAChR) are present primarily on the sar-
colemma of cardiomyocytes [12]. They respond to acetyl-
choline released from parasympathetic post-ganglionic
neurons, which innervate the ventricles [18, 39, 63, 74].
Indeed, their activation has been previously implicated in
cardioprotection, with exogenous acetylcholine inducing
powerful protection to isolated perfused rat hearts via an
Akt-dependent mechanism [45]. Thus, the observation that
atropine, a mAChR antagonist, abrogates dialysate-medi-
ated cardioprotection suggests that the humoral factor
induces increased intrinsic post-ganglionic parasympathetic
nerve outflow. Previous evidence has demonstrated that
hexamethonium and atropine abrogate in vivo RIC in rats
[22, 26, 51], although the literature is not in full agreement
[77]. However, it was not clear from these studies which
ganglia are important for the transmission of the RIC pro-
tective message. In addition, evidence that the endothelium
can be protected by RIC discounts the importance of
intrinsic nerves in responding to the humoral mediator [43].
However, the protection offered to endothelium by RIC
may be obtained via a different mechanism relative to the
myocardium. Our data suggest that the intrinsic cardiac
ganglia play an important role in this setting.
One interpretation of these data is that vagus nerve
stimulation may be sufficient to evoke all of the protection
conferred by RIC. In the literature, chronic vagal nerve
stimulation failed to ameliorate cardiac remodelling or
functional capacity in heart failure patients [81]. However,
whether vagus nerve stimulation can protect the heart from
acute myocardial infarction (AMI) in the clinic is unknown.
Perhaps, the cuff inflation used currently to induce RIC
could be replaced with non-invasive stimulation of the
vagus nerve [69]. A recent clinical study demonstrated that
the anesthetic propofol impedes the ability of RIC to protect
the heart [44]. Propofol is known to be inhibitory to vagus
nerve activity [75], thus suggesting the anesthetic prevents
the communication of RIC at the level of the parasympa-
thetic centres in the brainstem. Perhaps, RIC should be
given, while the patient remains conscious, prior to
administration of the anesthetic. Secondly, vagal tone is
thought to depreciate with age [40]. Therefore, given the
high average age of patients who suffer AMI, their dimin-
ished vagal tone may reduce the efficacy of RIC. Further
study is required to elucidate the effect of age and anes-
thetics on RIC, both in terms of vagal tone and function of
intrinsic cardiac ganglia. In addition, investigation into
which branch of the vagus nerve is responsible for inducing
release of the factor will help reveal the site of its release
and improve the chance of discovering its identity.
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